Influence of "high" defibrillation thresholds on patient survival and impact of system modification
- PMID: 34911148
- DOI: 10.1111/jce.15326
Influence of "high" defibrillation thresholds on patient survival and impact of system modification
Erratum in
-
Erratum for "Influence of "high" defibrillation thresholds on patient survival and impact of system modification". J Cardiovasc Electrophysiol. 2022;33: 234-240.J Cardiovasc Electrophysiol. 2022 Jun;33(6):1349. doi: 10.1111/jce.15460. Epub 2022 Apr 9. J Cardiovasc Electrophysiol. 2022. PMID: 35397132 No abstract available.
Abstract
Objective: To test whether a high defibrillation threshold (DFT) marks patients with poor outcomes which are improved when DFT is decreased by system modification (subcutaneous coil implant; SM).
Background: The electrical substrate generating fast ventricular arrhythmias may generate poor outcomes among patients treated with implantable cardioverter-defibrillators (ICDs), even when arrhythmias are treated successfully. Since patients with high DFTs have increased mortality, we contrasted survival among patients with high DFT treated with and without SM.
Methods: We studied consecutive patients undergoing ICD implantation and DFT testing at Cleveland Clinic over a 14-year period. High DFT was defined as successful defibrillation by shock strength >25 J or ≤10 J of maximal device output. Mortality was recorded using the Social Security Death Index. Survival was compared among those high DFT patients receiving SM versus the remainder.
Results: Out of 6353 patients tested, 191 (3%) had high DFT (32.1 ± 3.7 J) versus 13.9 ± 4.9 J in the remainder ("acceptable DFT," p < .001). One hundred twenty-one high DFT patients (63%; 33.3 ± 3.4 J) underwent SM, which significantly decreased DFT (24.8 ± 5.9 J; p < .001). Seventy patients (37%; 30.3 ± 3.3 J) did not undergo SM. During follow-up, 38% (2363/6162; 7.8 yrs) patients with acceptable DFT died versus 48% high DFT patients (91/191; 5.6 yrs.; p < .001). Concomitantly, 48% patients with SM (58/121) died, as compared to 47% patients (33/70) without SM (p = .91); median follow-up 4.9 yrs).
Conclusion: Patients with high DFT have a higher mortality than those with acceptable DFT. The additional subcutaneous coil implant decreases DFT to an acceptable range but does not appear to improve survival. The electrical substrate underlying high DFT appears to determine survival.
Keywords: defibrillation threshold test; survival; system modification.
© 2021 Wiley Periodicals LLC.
Comment in
-
High defibrillation threshold: Brace for impact.J Cardiovasc Electrophysiol. 2022 Feb;33(2):241-243. doi: 10.1111/jce.15327. Epub 2022 Jan 5. J Cardiovasc Electrophysiol. 2022. PMID: 34911152 No abstract available.
References
REFERENCES
-
- Aktas MK, Younis A, Zareba W, et al. Survival after implantable cardioverter- defibrillator shocks. J Am Coll Cardiol. 2021;77:2453-2462.
-
- Healey JS, Hohnloser SH, Glikson M, et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomized controlled trial (SIMPLE). Lancet. 2015;385(9970):785-791. doi:10.1016/S0140-6736(14)61903-6
-
- Bänsch D, Bonnemeier H, Brandt J, et al. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J. 2015;36(37):2500-2507.
-
- Duffett S, El Hajjaji I, Manlucu J, Yee R. Implantable cardioverter defibrillator implantation with or without defibrillation testing. Card Electrophysiol Clin. 2018;10(1):119-125.
-
- Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation. 1992;86(4):1206-1216.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical